首页 › 基金 › venBio Partners LLC › HRMY

venBio Partners LLC 对 HRMY 的持仓历史

HARMONY BIOSCIENCES HLDGS IN · 医疗保健

venBio Partners LLC 在 Q2 2026 的 13F 申报中披露持有 HRMY(HARMONY BIOSCIENCES HLDGS IN)472,194 股,市值约 US$17.2M,约占其申报组合的 3.31%,在其申报持仓中市值排名第 6 位。 venBio Partners LLC 最近 12 个申报季度中有 12 个季度披露了 HRMY 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q2 2026)472.19K 股
申报持仓市值$17.19M
组合权重3.31%
首次申报Q3 2023
最近变动减持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

venBio Partners LLC 对 HRMY 的持仓演变

venBio Partners LLC 于 Q3 2023 首次披露 HRMY 持仓:1,035,396 股(约 US$33.9M)。 该持仓在 Q1 2024 达到峰值 1,035,396 股,市值约 US$34.8M。 在 12 次申报中,venBio Partners LLC 0 次增持、4 次减持、7 次保持不变。 最近一期申报(Q2 2026)显示持股 472,194 股、市值约 US$17.2M,环比减持 -17,000 股。。 持仓曾出现大幅变动:Q3 2024 减持约 41% (随后一个季度股价下跌 14%)。

逐季持仓明细

季度股数金额变化
Q3 2023 1.04M $33.93M 新进
Q4 2023 1.04M $33.44M 持有
Q1 2024 1.04M $34.77M 持有
Q2 2024 1.04M $31.24M 持有
Q3 2024 614.59K $24.58M 减持
Q4 2024 539.19K $18.55M 减持
Q1 2025 489.19K $16.24M 减持
Q2 2025 489.19K $15.46M 持有
Q3 2025 489.19K $13.48M 持有
Q4 2025 489.19K $18.31M 持有
Q1 2026 489.19K $13.70M 持有
Q2 2026 472.19K $17.19M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 HRMY 与 13F 数据

HRMY(HARMONY BIOSCIENCES HLDGS IN)属于医疗保健行业。我们追踪的基金中还有 36 只申报持有 HRMY,申报仓位最大的包括:ARMISTICE CAPITAL, LLC (US$56.9M), Valor Management LLC (US$29.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 HRMY 的基金

查看 HRMY 的全部基金持有人 →

常见问题

How long has venBio Partners LLC held HRMY?

venBio Partners LLC has disclosed HRMY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is venBio Partners LLC's current position in HRMY?

As of Q2 2026, venBio Partners LLC holds 472.19K shares of HRMY (HARMONY BIOSCIENCES HLDGS IN), valued at $17.19M, representing 3.31% of its reported portfolio and ranking #6.

Has venBio Partners LLC been buying or selling HRMY?

In the latest 13F filing (Q2 2026), venBio Partners LLC reduced its position in HRMY. The position peaked in Q1 2024 at 1.04M shares.

Which other funds hold HRMY?

Other major institutional holders of HRMY include ARMISTICE CAPITAL, LLC, Valor Management LLC, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.